Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $475.00 | 1 | 77.6% |
| Food and Beverage | $137.19 | 7 | 22.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $475.00 | 1 | $0 (2017) |
| AXOGEN | $27.10 | 1 | $0 (2019) |
| Covidien LP | $24.07 | 1 | $0 (2018) |
| Smith+Nephew, Inc. | $22.28 | 1 | $0 (2020) |
| ACELL, INC. | $20.44 | 1 | $0 (2020) |
| AbbVie Inc. | $19.66 | 1 | $0 (2020) |
| MERZ NORTH AMERICA, INC. | $11.96 | 1 | $0 (2017) |
| Galderma Laboratories, L.P. | $11.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $62.38 | 3 | Smith+Nephew, Inc. ($22.28) |
| 2019 | $27.10 | 1 | AXOGEN ($27.10) |
| 2018 | $24.07 | 1 | Covidien LP ($24.07) |
| 2017 | $498.64 | 3 | Medtronic USA, Inc. ($475.00) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2020 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| 09/29/2020 | Smith+Nephew, Inc. | ACTICOAT (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Infection Management | ||||||
| 10/16/2019 | AXOGEN | AxoGuard Nerve Connector (Device), AxoGuard Nerve Protector | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Neurology | ||||||
| 12/21/2018 | Covidien LP | — | Food and Beverage | In-kind items and services | $24.07 | General |
| 11/30/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $11.96 | General |
| Category: Dermatology | ||||||
| 06/14/2017 | Medtronic USA, Inc. | PlasmaBlade (Device) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Advanced Energy Cutting Device | ||||||
| 04/28/2017 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.68 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 303 | 496 | $86,200 | $35,371 |
| 2022 | 10 | 463 | 718 | $147,870 | $57,935 |
| 2021 | 9 | 404 | 626 | $132,435 | $49,565 |
| 2020 | 14 | 566 | 709 | $197,145 | $65,709 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 386 | $55,970 | $25,108 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 48 | $7,680 | $4,449 | 57.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $5,850 | $3,073 | 52.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $7,700 | $1,516 | 19.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Facility | 2023 | 12 | 12 | $9,000 | $1,225 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 248 | 472 | $68,440 | $32,061 | 46.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $9,300 | $4,996 | 53.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 27 | 33 | $9,900 | $3,543 | 35.8% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 20 | 38 | $9,550 | $3,465 | 36.3% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 13 | 15 | $10,500 | $3,256 | 31.0% |
| 11442 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 17 | 17 | $8,500 | $2,510 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 23 | $3,680 | $2,079 | 56.5% |
| 11441 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 13 | 13 | $4,700 | $1,642 | 34.9% |
| 11403 | Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2022 | 11 | 13 | $4,550 | $1,548 | 34.0% |
| 11442 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Facility | 2022 | 18 | 21 | $10,500 | $1,494 | 14.2% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Facility | 2022 | 11 | 11 | $8,250 | $1,342 | 16.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 231 | 425 | $61,625 | $30,446 | 49.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 51 | 51 | $7,650 | $4,349 | 56.8% |
| 11442 | Removal of growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 16 | 20 | $10,000 | $2,891 | 28.9% |
| 11401 | Removal of growth (0.6 to 1.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 19 | 27 | $6,750 | $2,685 | 39.8% |
| 11643 | Removal of malignant growth (2.1 to 3.0 centimeters) of the face, ears, eyelids, nose, or lips | Facility | 2021 | 13 | 14 | $11,900 | $2,395 | 20.1% |
| 11442 | Removal of growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth | Facility | 2021 | 20 | 22 | $11,000 | $1,486 | 13.5% |
| 11441 | Removal of growth (0.6 to 1.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 13 | 14 | $4,900 | $1,457 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 16 | $2,560 | $1,441 | 56.3% |
| 11402 | Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Facility | 2021 | 17 | 26 | $7,800 | $1,362 | 17.5% |
About Dr. Mark Manstein, MD
Dr. Mark Manstein, MD is a Plastic and Reconstructive Surgery healthcare provider based in Huntingdon Valley, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033168729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Manstein, MD has received a total of $612.19 in payments from pharmaceutical and medical device companies, with $62.38 received in 2020. These payments were reported across 8 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($475.00).
As a Medicare-enrolled provider, Manstein has provided services to 1,736 Medicare beneficiaries, totaling 2,549 services with total Medicare billing of $208,580. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Plastic and Reconstructive Surgery
- Location Huntingdon Valley, PA
- Active Since 05/09/2006
- Last Updated 04/02/2015
- Taxonomy Code 2086S0122X
- Entity Type Individual
- NPI Number 1033168729
Products in Payments
- PlasmaBlade (Device) $475.00
- AxoGuard Nerve Connector (Device) $27.10
- ACTICOAT (Device) $22.28
- HUMIRA (Biological) $19.66
- Xeomin (Biological) $11.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.